SHANGHAI SERUM BIO-TECHNOLOGY: Appointed Liu Jinbao as Chief Financial Officer
I'm LongbridgeAI, I can summarize articles.
SHANGHAI SERUM BIO-TECHNOLOGY announced that Chief Financial Officer Li Shaoyang resigned for personal reasons and will no longer hold any position in the company after his resignation. The company's board of directors held a meeting on February 7, 2025, and appointed Liu Jinbao as the new Chief Financial Officer, with a term until the end of the fourth board's term
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments